Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?

Objectives: SARS-CoV-2 is responsible for the global COVID-19 pandemic, with little prevention or treatment options. More than 600 million mortalities have been documented from SARS-CoV-2 infection, with the majority of fatalities occurring among elderly patients (aged >65 years). A number of vac...

Full description

Bibliographic Details
Main Authors: Yiran E. Li, Shuyi Wang, Russel J. Reiter, Jun Ren
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:International Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971222004982
_version_ 1817979633768857600
author Yiran E. Li
Shuyi Wang
Russel J. Reiter
Jun Ren
author_facet Yiran E. Li
Shuyi Wang
Russel J. Reiter
Jun Ren
author_sort Yiran E. Li
collection DOAJ
description Objectives: SARS-CoV-2 is responsible for the global COVID-19 pandemic, with little prevention or treatment options. More than 600 million mortalities have been documented from SARS-CoV-2 infection, with the majority of fatalities occurring among elderly patients (aged >65 years). A number of vaccines have been developed in an effort to restrain the rapid spread of SARS-CoV-2. Considering the widespread administration of these vaccines, substantial side or undesired effects in multiple organ systems have emerged, necessitating essential critical care. Herein, we tabulate the adverse cardiovascular responses resulting from COVID-19 vaccines. Design or Methods: We searched PubMed for articles published through April, 2022, with the terms “SARS-CoV-2”, “COVID-19”, “cardiovascular”, “SARS-CoV-2 vaccines”, “COVID-19 vaccines”, “myocarditis”, “pericarditis”, “thrombosis”, “thrombocytopenia”, “vaccine-induced thrombotic thrombocytopenia”, “acute coronary syndrome”, “myocardial infarction”, “hypertension”, “arrythmia”, “postural orthostatic tachycardia syndrome”, “Takotsubo cardiomyopathy”, “cardiac arrest” and “death”. We mainly selected publications from the past 3 years, but did not exclude widely referenced and highly regarded older publications. Besides, we searched the reference lists of articles identified by above search method and chose those we considered relevant. Results: COVID-19 vaccines evoke rare but fatal thrombotic events, whereas messenger RNA/055based vaccines appear to be associated with risks of pericarditis/myocarditis, with the latter being more predominant in young adults following the second dose. Reports of other cardiovascular responses, including hypertension, arrhythmia, acute coronary syndrome, and cardiac arrest, have also been indicated. Conclusion: The undesired cardiovascular complications remain infrequent, giveng the large number of vaccinations inoculated to general population. And lower mortality takes precedence over the undesired cardiovascular complications.
first_indexed 2024-04-13T22:45:03Z
format Article
id doaj.art-db135d43afa04604817a83d4a7b778a3
institution Directory Open Access Journal
issn 1201-9712
language English
last_indexed 2024-04-13T22:45:03Z
publishDate 2022-11-01
publisher Elsevier
record_format Article
series International Journal of Infectious Diseases
spelling doaj.art-db135d43afa04604817a83d4a7b778a32022-12-22T02:26:27ZengElsevierInternational Journal of Infectious Diseases1201-97122022-11-01124110Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?Yiran E. Li0Shuyi Wang1Russel J. Reiter2Jun Ren3Shanghai Institute of Cardiovascular Diseases, Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, ChinaDepartment of Emergency, Shanghai Tenth People's Hospital, Tongji University, Shanghai, 200072, ChinaDepartment of Cellular and Structural Biology, UT Health San Antonio, San Antonio, USAShanghai Institute of Cardiovascular Diseases, Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai, 200032, China; Corresponding author.Objectives: SARS-CoV-2 is responsible for the global COVID-19 pandemic, with little prevention or treatment options. More than 600 million mortalities have been documented from SARS-CoV-2 infection, with the majority of fatalities occurring among elderly patients (aged >65 years). A number of vaccines have been developed in an effort to restrain the rapid spread of SARS-CoV-2. Considering the widespread administration of these vaccines, substantial side or undesired effects in multiple organ systems have emerged, necessitating essential critical care. Herein, we tabulate the adverse cardiovascular responses resulting from COVID-19 vaccines. Design or Methods: We searched PubMed for articles published through April, 2022, with the terms “SARS-CoV-2”, “COVID-19”, “cardiovascular”, “SARS-CoV-2 vaccines”, “COVID-19 vaccines”, “myocarditis”, “pericarditis”, “thrombosis”, “thrombocytopenia”, “vaccine-induced thrombotic thrombocytopenia”, “acute coronary syndrome”, “myocardial infarction”, “hypertension”, “arrythmia”, “postural orthostatic tachycardia syndrome”, “Takotsubo cardiomyopathy”, “cardiac arrest” and “death”. We mainly selected publications from the past 3 years, but did not exclude widely referenced and highly regarded older publications. Besides, we searched the reference lists of articles identified by above search method and chose those we considered relevant. Results: COVID-19 vaccines evoke rare but fatal thrombotic events, whereas messenger RNA/055based vaccines appear to be associated with risks of pericarditis/myocarditis, with the latter being more predominant in young adults following the second dose. Reports of other cardiovascular responses, including hypertension, arrhythmia, acute coronary syndrome, and cardiac arrest, have also been indicated. Conclusion: The undesired cardiovascular complications remain infrequent, giveng the large number of vaccinations inoculated to general population. And lower mortality takes precedence over the undesired cardiovascular complications.http://www.sciencedirect.com/science/article/pii/S1201971222004982SARS-CoV-2COVID-19 vaccinesCardiovascularMyocarditisPericarditisThrombotic thrombocytopenia
spellingShingle Yiran E. Li
Shuyi Wang
Russel J. Reiter
Jun Ren
Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
International Journal of Infectious Diseases
SARS-CoV-2
COVID-19 vaccines
Cardiovascular
Myocarditis
Pericarditis
Thrombotic thrombocytopenia
title Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
title_full Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
title_fullStr Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
title_full_unstemmed Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
title_short Clinical cardiovascular emergencies and the cellular basis of COVID-19 vaccination: from dream to reality?
title_sort clinical cardiovascular emergencies and the cellular basis of covid 19 vaccination from dream to reality
topic SARS-CoV-2
COVID-19 vaccines
Cardiovascular
Myocarditis
Pericarditis
Thrombotic thrombocytopenia
url http://www.sciencedirect.com/science/article/pii/S1201971222004982
work_keys_str_mv AT yiraneli clinicalcardiovascularemergenciesandthecellularbasisofcovid19vaccinationfromdreamtoreality
AT shuyiwang clinicalcardiovascularemergenciesandthecellularbasisofcovid19vaccinationfromdreamtoreality
AT russeljreiter clinicalcardiovascularemergenciesandthecellularbasisofcovid19vaccinationfromdreamtoreality
AT junren clinicalcardiovascularemergenciesandthecellularbasisofcovid19vaccinationfromdreamtoreality